-
PL Developments to sell, distribute store-brand generic Zegerid OTC
WESTBURY, N.Y. — PL Developments on Monday announced that it has acquired the exclusive rights to sell and distribute store-brand over-the-counter versions of omeprazole sodium bicarbonate capsules, the generic version of Merck’s Zegerid OTC.
Par Pharmaceutical currently has approval for the prescription product and has filed for the OTC version. Upon FDA approval and upon favorable resolution of intellectual property litigation, PL Developments will begin marketing the new store-brand proton-pump inhibitor, the company stated.
-
Lilly launches Axiron
INDIANAPOLIS — A topical medication for treating low testosterone in men now is available, drug maker Eli Lilly said.
Lilly announced the availability of Axiron (testosterone), a topical solution designed for application under the arm.
The Food and Drug Administration approved Axiron in November, making it the only testosterone replacement therapy applied to the underarm.